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Figure S1. CD8-1 Is a CD1c Restricted β-MPM Specific Reporter T Cell Line  
Mock transfected k562 cells and k562 stably transfected with the genes encoding CD1a, 
CD1b, CD1c and CD1d were used as antigen presenting cells (APC). The APC were 
incubated with and without 1 µM of C32 β-MPM and CD8-1 T cells were added for 24 
hours, after which levels of IL-2 released in the culture supernatant were determined by 
measuring 3H-thymidine incorporation by IL-2 dependent HT-2 cell line.  
 
 S2
Syntheses of MPM Analogs Including Characterization 
General experimental remarks: Reagents were purchased from Aldrich, Acros Chimica, Merck or 
Fluka and were used as received unless otherwise stated. All solvents were reagent grade and 
were dried and distilled before use according to standard procedures. Chromatography: silica gel, 
Merck type 9385 230-400 mesh, TLC: silica gel 60, Merck, 0.25 mm. Components were 
visualized by staining with KMnO4. EI-MS spectra were recorded on an AEI MS-902 and ESI-
MS measurements were carried out using a Quattro II, triple quadrupole mass spectrometer. 1H 
and 13C NMR spectra were recorded on a Varian AMX400 (100.59 MHz) spectrometer in CDCl3, 
CD3OD, D2O or mixtures of those solvents. Chemical shift values are denoted in δ values (ppm) 
relative to residual solvent peaks (CHCl3, 1H δ = 7.26, 13C δ = 76.9 or CH3OH, 1H δ = 3.31, 13C δ 
= 49.0). Multiplicity was determined by APT 13C experiments. The enantiomeric excess of  4 was 
determined by HPLC analysis on a Shimadzu LC-10ADVP HPLC equipped with a Shimadzu 
SPD-M10AVP diode array detector. Racemic 4 was prepared by reaction of  3 with MeMgBr at -
78 ºC in THF in the presence of CuI and TMSCl. Optical rotations were measured on a Schmidt + 





4-Benzyloxy-butan-1-ol (1):1 To a solution of butane-1,4-diol (5.0 ml, 55.5 mmol) in dry THF 
(36 ml) was added NaH (60%, 2.7 g, 55.5 mmol) at 0 ºC. Subsequently, BnBr (6.6 ml, 55.5 
mmol) in THF (12 ml) was added to the mixture followed by a small amount of DMF to increase 
solubility. The resulting suspension was stirred overnight under nitrogen at room temperature, 
after which the reaction was quenched with aq. NH4Cl (sat.). The aqueous layer was extracted 
with Et2O and the combined organic layers were washed with brine (sat.), dried (MgSO4) and 
concentrated. The product was purified by column chromatography (n-pentane-EtOAc 4:1 to 7:3) 
to give 4-benzyloxy-butan-1-ol (8.1 g, 44.9 mmol, 81%) as a light yellow oil. NMR-data were as 




                                                 
1  (a) Hashimoto, M.; Kan, T.; Nozaki, K.; Yanagiya, M.; Shirahama, H.; Matsumoto, T. J. Org. Chem. 1990, 55, 
5088-5107; (b) Harding, K. E.; Jones, M. W. Heterocycles 1989, 28, 663-668. 
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3-Benzyloxy-propionaldehyde (2):1 To a solution of PCC (5.3 g, 24.0 mmol, 2.2 eq) in DCM 
(38 ml) was added a solution of 4-benzyloxy-butan-1-ol (2.0 g, 11.0 mmol) in DCM (7 ml). The 
resulting dark green mixture was stirred under nitrogen overnight and then filtered over a silica 
plug (DCM). After concentration, 2 (1.2 g, 6.7 mmol, 61%) was obtained as a colorless liquid, 
which was used without further purification. 1H-NMR (CDCl3, 400 MHz) δ = 1.95 (m, 2H), 2.54 
(dt, J = 1.6, 6.8, 14.4 Hz, 2H), 3.50 (t, J = 6.4 Hz, 2H), 4.49 (s, 2H), 7.24-7.37 (m, 5H), 9.77 (t, J 
= 1.6 Hz, 1H) ppm. 13C-NMR (CDCl3, 100.6 MHz) δ = 22.3 (t), 40.7 (t), 68.9 (t), 72.7 (t), 







S-Ethyl (2E)-6-(benzyloxy)hex-2-enethioate (3):2 EtSC(O)C=PPh3 (1.21 g, 3.33 mmol, 1.1 eq) 
was added to a solution of 2 (540 mg, 3.03 mmol) in CHCl3 (35 ml) and the resulting mixture was 
refluxed under nitrogen for 3 h. The reaction mixture was cooled to room temperature and then 
stirred overnight in the presence of DMAP (100 mg, 0.82 mmol), after which the solvent was 
removed in vacuo. Trans-3 (more polar, 697 mg, 2.64 mmol, 87%) and a small amount of cis-3 
(less polar) were obtained as colorless oils after purification by column chromatography (n-
pentane-EtOAc 95:5 to 9:1). 
1H-NMR trans-3 (CDCl3, 400 MHz) δ = 1.28 (t, J = 7.6 Hz, 3H), 1.78 (m, 2H), 2.31 (m, 2H), 
2.94 (q, J = 7.6 Hz, 2H), 3.49 (t, J = 6.4 Hz, 2H), 4.50 (s, 2H), 6.11 (d, J = 15.2 Hz, 1H), 6.90 (dt, 
J = 7.2, 15.2 Hz, 1H), 7.26-7.37 (m, 5H) ppm. 13C-NMR trans-3  (CDCl3, 100.6 MHz) δ = 14.6 
(q), 22.9 (t), 27.9 (t), 28.7 (t), 69.0 (t), 72.8 (t), 127.42 (d), 127.44 (d), 128.2 (d), 128.8 (d), 138.2 
(s), 144.3 (d), 189.9 (s) ppm. MS (EI) for C15H20O2S-C2H5: m/z = 235 [M+]. 
1H-NMR cis-3 (CDCl3, 400 MHz) δ = 1.28 (t, J = 7.6 Hz, 3H), 1.78 (m, 2H), 2.74 (m, 2H), 2.92 
(q, J = 7.6 Hz, 2H), 3.50 (t, J = 6.4 Hz, 2H), 4.50 (s, 2H), 5.98-6.08 (m, 2H), 7.26-7.36 (m, 5H) 
ppm. 13C-NMR cis-3 (CDCl3, 100.6 MHz) δ = 14.6 (q), 23.1 (t), 26.7 (t), 29.1 (t), 69.6 (t), 72.8 (t), 
                                                 
2 Van Summeren, R.; Moody, D. B.; Feringa, B. L.; Minnaard, A. J. J. Am. Chem. Soc. 2006, 128, 4546-4547.  
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126.5 (d), 127.4 (d), 127.5 (d), 128.2 (d), 138.3 (s), 146.0 (d), 189.7 (s) ppm. MS (EI) for 













S-Ethyl (3R)-6-(benzyloxy)-3-methylhexanethioate ((3R)-4):2 (R,S)-Josiphos (L*, 67 mg, 0.11 
mmol, 6 mol%) and CuBr·SMe2 (19 mg, 0.09 mmol, 5 mol%) were dissolved in t-BuOMe (17 
ml) and stirred for 30 min under nitrogen at room temperature. The mixture was cooled at -78 ºC 
and MeMgBr (3.0 M in Et2O, 0.78 ml, 2.3 mmol, 1.3 eq) was added dropwise over 2 min. After 
stirring for 10 min, a solution of trans-3 (495 mg, 1.87 mmol) in t-BuOMe (2 ml) was added over 
5 h by syringe pump and the resulting mixture was stirred overnight at -78 ºC. The reaction was 
quenched with MeOH at -78 ºC, removed from the cold bath and diluted with H2O, aq. NH4Cl 
(sat.) and Et2O. The product was extracted with Et2O, the combined organic layers were washed 
with brine (sat.), dried (MgSO4) and concentrated. (3R)-4 (485 mg, 1.73 mmol, 92%, 93% ee) 
was isolated as a colorless liquid after purification by column chromatography (n-pentane-EtOAc 
95:5). [α]D22 = +5.1 º (c = 1.88, CHCl3). 1H-NMR (CDCl3, 400 MHz) δ = 0.94 (d, J = 6.8 Hz, 
3H), 1.24 (t, J = 7.6 Hz, 3H), 1.22-1.31 (m, 1H), 1.41 (m, 1H), 1.63 (m, 2H), 1.94 (m, 1H), 2.36 
(dd, J = 8.4, 14.4 Hz, 1H), 2.54 (dd, J = 5.6, 14.4 Hz, 1H), 2.87 (q, J = 7.2 Hz, 2H), 3.45 (t, J = 
6.4 Hz, 2H), 4.50 (s, 2H), 7.26-7.37 (m, 5H) ppm. 13C-NMR (CDCl3, 100.6 MHz) δ = 14.7 (q), 
19.3 (q), 23.2 (t), 27.0 (t), 30.8 (d), 32.9 (t), 51.2 (t), 70.3 (t), 72.8 (t), 127.4 (d), 127.5 (d), 128.2 
(d), 138.4 (s), 199.1 (s) ppm. MS(EI) for C16H24O2S: m/z = 280 [M+], HRMS calcd for 
C16H24O2S: 280.150, found: 280.149. Ee determination by chiral HPLC analysis, chiralcel OD-H 








S-Ethyl (3S)-6-(benzyloxy)-3-methylhexanethioate ((3S)-4): (S,R)-Josiphos (L*, 34 mg, 0.06 
mmol, 6 mol%) and CuBr·SMe2 (10 mg, 0.05 mmol, 5 mol%) were dissolved in t-BuOMe (9 ml) 
and stirred for 30 min under nitrogen at room temperature. The mixture was cooled at -78 ºC and 
MeMgBr (3.0 M in Et2O, 0.40 ml, 1.18 mmol, 1.3 eq) was added dropwise over 2 min. After 
stirring for 10 min, a solution of trans-3 (250 mg, 0.94 mmol) in t-BuOMe (1 ml) was added over 
5 h by syringe pump and the resulting mixture was stirred overnight at -78 ºC. The reaction was 
quenched with MeOH at -78 ºC, removed from the cold bath and diluted with H2O, aq. NH4Cl 
(sat.) and Et2O. The product was extracted with Et2O, the combined organic layers were washed 
with brine (sat.), dried (MgSO4) and concentrated. (3S)-4 (225 mg, 0.80 mmol, 85%, 95% ee) 
was isolated as a colorless liquid after purification by column chromatography (n-pentane-EtOAc 
95:5). [α]D22 = -4.5 º (c = 1.20, CHCl3).  Ee determination by chiral HPLC analysis, chiralcel OD-





6-Benzyloxy-(3R)-methyl-hexan-1-ol ((3R)-5):2 (3R)-4 (555 mg, 1.98 mmol) was dissolved in 
THF (6 ml) and LiAlH4 (188 mg, 4.95 mmol, 2.5 eq) was added at 0 ºC. The resulting suspension 
was stirred for 45 min at 0 ºC under nitrogen and then quenched with water. NaOH (3 M aq.) was 
added and the mixture was stirred until two clear layers were obtained. The layers were separated 
and the aqueous layer was extracted with Et2O. The combined organic layers were washed with 
brine (sat.), dried (MgSO4) and concentrated. Purification by column chromatography (n-pentane-
EtOAc 7:3) gave (3R)-5 (421 mg, 1.89 mmol, 96%) as a colorless liquid. [α]D22 = +4.9 º (c = 1.10, 
CHCl3). 1H-NMR (CDCl3, 400 MHz) δ = 0.90 (d, J = 6.8 Hz, 3H), 1.22 (m, 1H), 1.40 (m, 2H), 
1.54-1.73 (m, 4H), 3.46 (t, J = 6.4 Hz, 2H), 3.67 (m, 2H), 4.50 (s, 2H), 7.26-7.37 (m, 5H) ppm. 
13C-NMR (CDCl3, 100.6 MHz) δ = 19.4 (q), 27.0 (t), 29.2 (d), 33.3 (t), 39.7 (t), 61.0 (t), 70.6 (t), 
72.8 (t), 127.4 (d), 127.5 (d), 128.2 (d), 138.5 (s) ppm. MS(EI) for C14H22O2: m/z = 222 [M+], 






6-Benzyloxy-(3S)-methyl-hexan-1-ol ((3S)-5):  (3S)-4 (225 mg, 0.80 mmol) was dissolved in 
THF (2 ml) and LiAlH4 (76 mg, 2.00 mmol, 2.5 eq) was added at 0 ºC. The resulting suspension 
was stirred for 45 min at 0 ºC under nitrogen and then quenched with water. NaOH (3 M aq.) was 
added and the mixture was stirred until two clear layers were obtained. The layers were separated 
and the aqueous layer was extracted with Et2O. The combined organic layers were washed with 
brine (sat.), dried (MgSO4) and concentrated. Purification by column chromatography (n-pentane-







6-Benzyloxy-(3R)-methyl-hexyl p-toluensulfonate ((3R)-6): (3R)-5 (100 mg, 0.45 mmol) was 
dissolved in DCM (2 ml) and then pyridine (180 μl, 2.25 mmol,  5.0 eq) and p-TsCl (255 mg, 
1.35 mmol,  3.0 eq) were added. The resulting solution was stirred at room temperature under 
nitrogen overnight and then quenched with NaHCO3 (sat.). The aqueous layer was extracted with 
DCM and the combined organic layers were dried (MgSO4) and concentrated. Purification by 
column chromatography (n-pentane-EtOAc 95:5) gave (3R)-6 (152 mg, 0.41 mol, 90 %) as a 
colorless oil.  
[α]D22 = +4.5 º (c = 1.15, CHCl3). 1H-NMR (CDCl3, 400 MHz) δ = 0.82 (d, J = 6.4 Hz, 3H), 1.17 
(m, 1H), 1.29 (m, 1H), 1.39-1.75 (m, 5H), 2.43 (s, 3H), 3.41 (t, J = 6.8 Hz, 2H), 4.06 (m, 2H), 
4.48 (s, 2H), 7.26-7.38 (m, 7H), 7.77 (s, 1H), 7.79 (s, 1H) ppm. 13C-NMR (CDCl3, 100.6 MHz) δ 
= 19.0 (q), 21.6 (q), 27.0 (t), 29.1 (d), 33.0 (t), 35.6 (t), 68.9 (t), 70.4 (t), 72.8 (t), 127.4 (d), 127.5 
(d), 127.8 (d), 128.3 (d), 129.8 (d), 133.2 (s), 138.5 (s), 144.6 (s) ppm. MS(EI) for C21H28O4S: 





6-Benzyloxy-(3S)-methyl-hexyl p-toluensulfonate ((3S)-6): (3S)-5 (150 mg, 0.67 mmol) was 
dissolved in DCM (3 ml) and then pyridine (270 μl, 3.37 mmol,  5.0 eq) and p-TsCl (383 mg, 
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2.01  mmol,  3.0 eq) were added. The resulting solution was stirred at room temperature under 
nitrogen overnight and then quenched with NaHCO3 (sat.). The aqueous layer was extracted with 
DCM and the combined organic layers were dried (MgSO4) and concentrated. Purification by 
column chromatography (n-pentane-EtOAc 95:5) gave (3R)-6 (222 mg, 0.59 mmol, 88%) as a 




1-bromo-heneicosane (7): To a solution of heneicosanol (900 mg, 2.88 mmol) in DCM (20 ml) 
was added PPh3 (910 mg, 3.46 mmol, 1.2 eq) followed by NBS (320 mg, 3.46 mmol, 1.2 eq) at 0 
ºC. The resulting solution was stirred under nitrogen at 0 ºC for 10 min and then warmed to room 
temperature over 1 h. The reaction mixture was quenched with aq. NaHCO3 (sat.) and the 
aqueous layer was extracted with DCM. The combined organic layers were washed with aq. 
Na2S2O3 (10% v/v) and brine (sat.), dried (MgSO4), filtered and concentrated. The resulting 
brown solid was suspended in n-pentane and filtered, after which the residue was washed with n-
pentane. The filtrate was concentrated to give 7 (1.06 g, mol, 98%) as a white solid. 1H-NMR 
(CDCl3, 400 MHz) δ = 0.85 (t, J = 6.4 Hz, 3H), 1.00-1.43 (m, 36H), 1.83 (m, 2H), 3.38 (t, J = 6.8 
Hz, 2H) ppm. 13C-NMR (CDCl3, 100.6 MHz) δ = 14.1 (q), 22.7 (t), 28.1(t), 28.7 (t), 29.3 (t), 29.4 
(t), 29.5 (t), 29.6 (t), 29.7 (t), 31.9 (t), 32.8 (t), 33.8 (t) ppm. MS(EI) for C21H43Br: m/z = 374 




((4S)-Methyl-heptacosyloxymethyl)-benzene ((4S)-8): 1-bromoheneicosane (7) (880 mg, 2.34 
mmol) in dry THF (5.3 ml) was added dropwise to Mg (80 mg, 3.28 mmol, 1.4 eq) in a nitrogen-
purged flask and then stirred for 1.5 h at 40 ºC. The resulting solution was titrated with sec-
butanol in the presence of 1,10-phenanthroline, showing the concentration of C21H43MgBr to be 
0.38 M. The Grignard reagent (3.4 ml, 1.28 mmol, 4.0 eq) was added in a dropwise fashion to a 
solution of  (3R)-6 (120 mg, 0.32 mmol) and CuBr.SMe2 (16 mg, 0.08 mmol, 25% mol) in dry 
THF (2.0 ml)  at 0 ºC under nitrogen. After stirring for 2 h at 0 ºC, the solution was allowed to 
warm to room temperature and stirred overnight. The reaction was quenched with aq. NH4Cl 
 S8
(sat.), extracted with Et2O and the combined organic layers were washed with brine (sat.), dried 
(MgSO4) and concentrated. (4S)-8 (128 mg, 0.26 mmol, 80%) was isolated as a white solid after 
purification by column chromatography (n-pentane to n-pentane-EtOAc 95:5). 1H-NMR (CDCl3, 
400 MHz) δ = 0.87 (d, J = 6.5 Hz, 3H), 0.89 (t, J = 6.5 Hz, 3H), 1.10-1.45 (m, 47H), 1.63 (m, 
2H), 3.46 (t, J = 6.7 Hz, 2H), 4.51 (s, 2H), 7.29 (m, 1H), 7.34 (s, 2H), 7.35 (s, 2H)  ppm. 13C-
NMR (CDCl3, 100.6 MHz) δ = 14.1 (q), 19.6 (q), 22.7 (t), 27.1 (t), 27.3 (t), 29.4 (t), 29.7 (t), 30.0 
(t), 31.9 (t), 32.6 (d), 33.3 (t), 37.0 (t), 70.9 (t), 72.9 (t), 127.4 (d), 127.6 (d), 128.3 (d), 138.7 (s) 




((4R)-Methyl-heptacosyloxymethyl)-benzene ((4R)-8): 1-bromoheneicosane (7) (650 mg, 1.73 
mmol) in dry THF (4.0 ml) was added dropwise to Mg (60 mg, 2.45 mmol, 1.4 eq) in a nitrogen-
purged flask and then stirred for 1.5 h at 40 ºC. The resulting solution was titrated with sec-
butanol in the presence of 1,10-phenanthroline, showing the concentration of C21H43MgBr to be 
0.38 M. The Grignard reagent (2.7 ml, 1.02 mmol, 4.0 eq) was added in a dropwise fashion to a 
solution of  (3S)-6 (96 mg, 0.25 mmol) and CuBr.SMe2 (13 mg, 0.06 mmol, 25% mol) in dry THF 
(1.6 ml)  at 0 ºC under nitrogen. After stirring for 2 h at 0 ºC, the solution was allowed to warm to 
room temperature and stirred overnight. The reaction was quenched with aq. NH4Cl (sat.), 
extracted with Et2O and the combined organic layers were washed with brine (sat.), dried 
(MgSO4) and concentrated. (4R)-8 (99 mg, 0.20 mmol, 78%) was isolated as a white solid after 
purification by column chromatography (n-pentane to n-pentane-EtOAc 95:5). MS(EI) for 




(4S)-Methyl-heptacosan-1-ol ((4S)-9): (4S)-8 (70 mg, 0.14 mmol) was dissolved in EtOAc (6 
ml) and Pd/C (10%, 35 mg) was added. The resulting suspension was degassed with 3 vacuum-
nitrogen cycles and then saturated with H2 by 5 vacuum-H2 cycles. After stirring for 48 h under 
an H2-atmosphere (1 bar), the Pd/C was removed by filtration over celite and the resulting clear 
 S9
solution was concentrated in vacuo. After purification by column chromatography (n-pentane-
EtOAc 95:5) (4S)-9 (53 mg, 0.13, 92%) was isolated as a white solid. 1H-NMR (CDCl3, 400 
MHz) δ = 0.87 (d, J = 5.6 Hz, 3H), 0.88 (t, J = 6.8 Hz, 3H), 1.10-1.39 (m, 47H), 1.56 (m, 2H), 
3.62 (t, J = 6.8 Hz, 2H) ppm. 13C-NMR (CDCl3, 100.6 MHz) δ = 14.1 (q), 19.6 (q), 22.7 (t), 27.0 
(t), 29.4 (t), 29.7 (t), 30.0 (t), 30.3 (t), 31.9 (t), 32.6 (d), 32.9 (t), 37.0 (t), 63.5 (t) ppm. MS(EI) for 




(4R)-Methyl-heptacosan-1-ol ((4R)-9): (4R)-8 (90 mg, 0.18 mmol) was dissolved in EtOAc (7 
ml) and Pd/C (10%, 45 mg) was added. The resulting suspension was degassed with 3 vacuum-
nitrogen cycles and then saturated with H2 by 5 vacuum-H2 cycles. After stirring for 48 h under 
an H2-atmosphere (1 bar), the Pd/C was removed by filtration over celite and the resulting clear 
solution was concentrated in vacuo. After purification by column chromatography (n-pentane-
EtOAc 95:5) (4R)-9 (58 mg, 0.14, 78%) was isolated as a white solid. MS(EI) for C28H58O-H2O 




9-Benzyloxy-nonan-1-ol (10): To a solution of nonane-1,9-diol (200 mg, 1.25 mmol) in dry THF 
(5 ml) was added NaH (60%, 50 mg, 1.25 mmol, 1.0 eq) at 0 ºC. Subsequently, BnBr (160 µl, 
1.38 mmol, 1.1 eq) was added to the mixture and a small amount of DMF to increase solubility. 
The resulting suspension was stirred overnight under nitrogen at room temperature, after which 
the reaction was quenched with aq. NH4Cl (sat.). The aqueous layer was extracted with Et2O and 
the combined organic layers were washed with brine (sat.), dried (MgSO4) and concentrated. The 
product was purified by column chromatography (n-pentane-EtOAc 7:3) to give 10 (250 mg, 1.00 
mmol, 80%) as a light yellow oil. 1H-NMR (CDCl3, 400 MHz) δ = 1.18-1.35 (m, 10H), 1.51-1.66 
(m, 5H, 2CH2 and OH), 3.46 (t, J = 6.8 Hz, 2H), 3.61 (t, J = 6.4 Hz, 2H), 4.50 (s, 2H), 7.27 (m, 
1H), 7.33 (s, 2H), 7.34 (s, 2H) ppm. 13C-NMR (CDCl3, 100.6 MHz) δ = 25.7 (t), 26.1 (t), 29.3 (t), 
29.4 (t), 29.5 (t), 29.7 (t), 32.7 (t), 62.9 (t), 70.4 (t), 72.8 (t), 127.4 (d), 127.6 (d), 128.3 (d), 138.6 
 S10
(s) ppm. MS(EI) for C16H26O2: m/z = 250 [M+], HRMS calcd for C16H26O2: 250.193, found: 
250.194.  
 
BnO OTs  
 
9-Benzyloxy-nonyl p-toluensulfonate (11): 10 (200 mg, 0.80 mmol) was dissolved in DCM (4 
ml) and then pyridine (320 μl, 4.00 mmol,  5.0 eq) and p-TsCl (457 mg, 2.40  mmol,  3.0 eq) 
were added. The resulting solution was stirred at room temperature under nitrogen overnight and 
then quenched with NaHCO3 (sat.). The aqueous layer was extracted with DCM and the 
combined organic layers were dried (MgSO4) and concentrated. Purification by column 
chromatography (n-pentane-EtOAc 95:5) gave 11 (285 mg, 0.70 mmol, 89%) as a colorless oil. 
1H-NMR (CDCl3, 400 MHz) δ = 1.17-1.35 (m, 10H), 1.55-1.65 (m, 4H), 2.43 (s, 3H), 3.45 (t, J = 
6.4 Hz, 2H), 4.01 (t, J = 6.4 Hz, 2H), 4.49 (s, 2H), 7.26-7.34 (m, 7H), 7.77 (s, 2H), 7.79 (s, 2H) 
ppm. 13C-NMR (CDCl3, 100.6 MHz) δ = 21.5 (q), 25.2 (t), 26.0 (t), 28.7 (t), 29.2 (t), 29.6 (t), 






Heptacosyloxymethyl-benzene (12): Octadecyl bromide (800 mg, 2.40 mmol) in dry THF (5.4 
ml) was added dropwise to Mg (82 mg, 3.37 mmol, 1.4 eq) in a nitrogen-purged flask and then 
stirred for 1.5 h at 40 ºC. The resulting solution was titrated with sec-butanol in the presence of 
1,10-phenanthroline, showing the concentration of C21H43MgBr to be 0.30 M. The Grignard 
reagent (5.0 ml, 1.50 mmol, 3.4 eq) was added in a dropwise fasion to a solution of  11 (180 mg, 
0.44 mmol) and CuBr.SMe2 (23 mg, 0.11 mmol, 25% mol) in dry THF (2.7 ml)  at 0 ºC under 
nitrogen. After stirring for 2 h at 0 ºC, the solution was allowed to warm to room temperature and 
stirred overnight. The reaction was quenched with aq. NH4Cl (sat.), extracted with Et2O and the 
combined organic layers were washed with brine (sat.), dried (MgSO4) and concentrated. 12 (183 
mg, 0.37 mmol, 84%) was isolated as a white solid after purification by column chromatography 
(n-pentane to n-pentane-EtOAc 95:5). 1H-NMR (CDCl3, 400 MHz) δ = 0.89 (d, J = 4.8 Hz, 3H), 
1.05-1.48 (m, 48H), 1.61 (m, 2H), 3.46 (t, J = 8.4 Hz, 2H), 4.51 (s, 2H), 7.28 (m, 1H), 7.34 (s, 
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2H), 7.35 (s, 2H)  ppm. 13C-NMR (CDCl3, 100.6 MHz) δ = 14.1 (q), 22.7 (t), 26.2 (t), 29.4 (t), 
29.5 (t), 29.6 (t), 29.7 (t), 29.8 (t), 31.9 (t), 70.5 (t), 72.8 (t), 127.4 (d), 127.6 (d), 128.3 (d) ppm. 




Heptacosanol (13): 12 (163 mg, 0.33 mmol) was dissolved in EtOAc (14 ml) and Pd/C (10%, 82 
mg) was added. The resulting suspension was degassed with 3 vacuum-nitrogen cycles and then 
saturated with H2 by 5 vacuum-H2 cycles. After stirring for 48 h under an H2-atmosphere (1 bar), 
a suspension was obtained. Toluene was added to get a clear solution and then the Pd/C was 
removed by filtration over celite. The resulting solution was concentrated in vacuo and after 
purification by column chromatography (n-pentane-EtOAc 95:5), 13 (110 mg, 0.28, 84%) was 
isolated as a white solid. 1H-NMR (CDCl3, 400 MHz) δ = 0.88 (t, J = 6.6 Hz, 3H), 1.08-1.38 (m, 
48H), 1.56 (m, 2H), 3.64 (t, J = 6.5 Hz, 2H) ppm. 13C-NMR (CDCl3, 100.6 MHz) δ = 14.1 (q), 
22.7 (t), 25.7 (t), 29.4 (t), 29.6 (t), 29.7 (t), 31.9 (t), 32.8 (t), 63.1 (t) ppm. MS(EI) for C27H56O-













Diphenyl-(2,3,4,6-tetra-O-acetyl-β-D-mannopyranosyl)-phosphate (β-14):3  To a solution of 
2,3,4,6-tetra-O-acetyl-D-mannopyranose (1.90 g, 5.46 mmol) and DMAP (1.52 g, 12.40 mmol, 
2.3 eq) in DCM (32 ml) at room temperature was added a solution of diphenyl chlorophosphate 
(2.66 ml, 12.80 mmol, 2.4 eq) in DCM (13 ml) by syringe pump over 1 h. After stirring the 
resulting solution under nitrogen for 2 h, the reaction mixture was diluted with DCM and washed 
with cold water, cold aq. HCl (0.5 M) and cold aq. NaHCO3 (sat.). The organic layer was dried 
(MgSO4), filtered and concentrated to give 14 (2.50 g, 4.31 mmol, 79%) as a mixture of anomers 
(ratio α:β = 1:4). The pure β-anomer of 14 (0.98 g, 1.69 mmol, 31%) was obtained after 
purification by column chromatography (n-pentane-EtOAc 8:3 to 3:2) together with a mixed 
                                                 
3 Sabesan, S.; Neira, S. Carbohydr. Res. 1992, 223, 169-185. 
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fraction of anomers (1.40g, 2.41 mmol, 44%). β-14 was stable in solution at room temperature 
and for several months at -18 ºC when concentrated. 1H-NMR β-14 (CDCl3, 400 MHz) δ = 1.94 
(s, 3H, Ac), 2.00 (s, 6H, Ac), 2.05 (s, 3H, Ac), 3.77 (m, 1H, C5-H), 4.07 (dd, J = 2.4, 12.4 Hz, 1H, 
C6-H), 4.23 (dd, J = 5.6, 12.4 Hz, 1H, C6-H’), 5.07 (dd, J = 3.6, 9.6 Hz, 1H, C3-H), 5.22 (t, J = 
9.6 Hz, 1H, C4-H), 5.46 (d, J = 3.2 Hz, 1H, C2-H), 5.61 (d, J = 6.8 Hz, 1H, C1-H), 7.12-7.32 (m, 
10H) ppm. 13C-NMR (CDCl3, 100.6 MHz) δ = 20.2 (q), 20.3 (q), 20.37 (q), 20.38 (q), 61.7 (t), 
65.0 (d), 67.8 (d, JC-P = 8.5 Hz), 69.8 (d), 72.7 (d), 94.5 (d, JC-P = 4.6 Hz), 120.0 (d, JC-P = 4.5 Hz), 
120.1 (d, JC-P = 4.5 Hz), 125.4 (d), 125.6 (d), 129.4 (d), 129.6 (d), 149.7 (s, JC-P = 7.6 Hz), 150.1 













Pyridinium (2,3,4,6-tetra-O-acetyl-β-D-mannopyranosyl)-phosphate (β-15): β-14 (667 mg, 
1.15 mmol) was dissolved in EtOH-EtOAc (14 ml, 1:1 v/v) and PtO2 (29 mg, 0.13 mmol, 0.11 
eq) was added. The resulting suspension was degassed with 3 vacuum-argon cycles and then 
saturated with H2 by 5 vaccum-H2 cycles. After stirring for 60 h under an H2-atmosphere (1 bar), 
the catalyst was removed by filtration over celite and the solution was neutralized with pyridine. 
After concentration, β-15 (469 mg, 0.92 mmol, 80%) was isolated as a white foam. 1H-NMR β-
15 (D2O, 400 MHz) δ = 1.88 (s, 3H, Ac), 1.96 (s, 3H, Ac), 1.99 (s, 3H, Ac), 2.10 (s, 3H, Ac), 
3.93 (ddd, J = 2.0, 3.6, 10.0 Hz, 1H, C5-H), 4.07 (dd, J = 2.0, 12.8 Hz, 1H, C6-H), 4.31 (dd, J = 
3.6, 12.8 Hz, 1H, C6-H’), 5.09 (t, J = 10 Hz, 1H, C4-H), 5.21 (dd, J = 3.2, 10.4 Hz, 1H, C3-H), 
5.33 (dd, J = 0.8, 8.8 Hz, 1H, C1-H), 5.40 (d, J = 2.8 Hz, 1H, C2-H), 7.95 (t, J = 7.2 Hz, 2H, Py), 
8.50 (m, 1H, Py), 8.65 (d, J = 5.2 Hz, 2H, Py) ppm. 13C-NMR (D2O, 100.6 MHz) δ = 18.6 (q), 
60.3 (t), 64.0 (d), 68.5 (d, JC-P = 6.8 Hz), 69.6 (d), 70.3 (d), 91.8 (d), 125.9 (d), 171.1 (s), 171.6 
(s), 171.7 (s), 172.2 (s) ppm. Positive ion ESI-HRMS calcd for C14H21O13NaP (M-C5H6N+ + Na+ 















15 (55 mg, 0.107 mmol, 2.0 eq) was brought into a dry Schlenk tube and co-evaporated with 
freshly distilled dry toluene (2x; pressure elevated with nitrogen). Subsequently, a solution of 
(4S)-9 (22 mg, 0.054 mmol) in dry toluene was added and the mixture was co-evaporated with 
dry toluene (2x). Finally, 2,4,6-triisopropylbenzenesulfonyl chloride (TPSCl) (49 mg, 0.162 
mmol, 3.0 eq) was added and after two more additions and evaporations of dry toluene, the 
residue was dissolved in dry pyridine (1.5 ml) and stirred under nitrogen for 4 days. The reaction 
was quenched with MeOH (1.5 ml) and stirred for 2 more h before concentration (co-evaporation 
with toluene). The residue was purified by column chromatography (chloroform-MeOH 95:5) 
giving (4S)-β-16 (33 mg, 0.040 mmol, 75%) as a white solid. 1H-NMR (CDCl3-CD3OD 1:1 v/v, 
400 MHz) δ = 0.83 (d, J = 6.4 Hz, 3H), 0.85 (t, J = 6.4 Hz, 3H), 0.98-1.40 (m, 47H), 1.56 (m, 
2H), 1.96 (s, 3H, Ac), 2.04 (s, 3H, Ac), 2.06 (s, 3H, Ac), 2.15 (s, 3H, Ac), 3.81 (m, 3H, C5-H and 
CH2-OP), 4.15 (dd, J = 2.4, 12.4 Hz, 1H, C6-H), 4.26 (dd, J = 4.8, 12.4 Hz, 1H, C6-H’), 5.12 (dd, 
J = 3.2, 10.4 Hz, 1H), 5.22 (t, J = 10.0 Hz, 1H), 5.35 (d, J = 8.0 Hz, 1H, C1-H), 5.44 (d, J = 2.8 
Hz, 1H, C2-H) ppm. 13C-NMR (CDCl3-CD3OD 1:1 v/v, 100.6 MHz) δ = 14.3 (q), 19.8 (q), 20.7 
(t), 20.8 (t), 23.1 (t), 27.6 (t), 28.6 (t), 28.7 (t), 29.8 (t), 30.1 (t), 30.2 (t), 30.5 (t), 32.4 (t), 33.2 (d), 
33.5 (t), 37.5 (t), 62.8 (t), 66.2 (d), 67.1 (t, JC-P = 4.3 Hz), 70.2 (d, JC-P = 5.5 Hz), 71.7 (d), 73.0 
(d), 94.2 (d), 170.7 (s), 171.4 (s), 171.7 (s) ppm. 31P-NMR (CDCl3-CD3OD 1:1 v/v, 161.6 MHz) 













β-15 (55 mg, 0.107 mmol, 2.0 eq) was brought into a dry Schlenk tube and co-evaporated with 
freshly distilled dry toluene (2x; pressure elevated with nitrogen). Subsequently a solution of 
(4R)-9 (22 mg, 0.054 mmol) in dry toluene was added and the mixture was co-evaporated with 
dry toluene (2x). Finally TPSCl (49 mg, 0.162 mmol, 3.0 eq) was added and after two more 
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additions and evaporations of dry toluene, the residue was dissolved in dry pyridine (1.5 ml) and 
stirred under nitrogen for 4 days. The reaction was quenched with MeOH (1.5 ml) and stirred for 
2 more h before concentration (co-evaporation with toluene). The residue was purified by column 
chromatography (chloroform-MeOH 95:5) giving (4R)-β-16 (30 mg, 0.037 mmol, 68%) as a 













Heptacosylphosphoryl-2,3,4,6-tetra-O-acetyl-β-D-mannopyranoside (17): β-15 (78 mg, 0.151 
mmol, 2.0 eq) was brought into a dry Schlenk tube and co-evaporated with freshly distilled dry 
toluene (2x; pressure elevated with nitrogen). Subsequently a solution of 13 (30 mg, 0.076 mmol) 
in dry toluene was added and the mixture was co-evaporated with dry toluene (2x). Finally TPSCl 
(69 mg, 0.228 mmol, 3.0 eq) was added and after two more additions and evaporations of dry 
toluene, the residue was dissolved in a mixture of dry toluene (1.0 ml) and dry pyridine (1.0 ml). 
The mixture was stirred under nitrogen for 4 days. The reaction was quenched with MeOH (1.5 
ml) and stirred for 2 more h before concentration (co-evaporation with toluene). The residue was 
purified by column chromatography (chloroform-MeOH 95:5) giving β-17 (20 mg, 0.025 mmol, 
33%) as a white solid. 1H-NMR (CDCl3-CD3OD 1:1 v/v, 400 MHz) δ = 0.87 (t, J = 6.8 Hz, 3H), 
1.06-1.38 (m, 48H), 1.58 (m, 2H), 1.96 (s, 3H, Ac), 2.04 (s, 3H, Ac), 2.07 (s, 3H, Ac), 2.16 (s, 3H, 
Ac), 3.84 (m, 3H, C5-H and CH2-OP), 4.15 (dd, J = 2.0, 12.4 Hz, 1H, C6-H), 4.27 (dd, J = 4.8, 
12.4 Hz, 1H, C6-H’), 5.15 (dd, J = 2.8, 10.4 Hz, 1H), 5.22 (t, J = 10.0 Hz, 1H), 5.37 (d, J = 6.4 
Hz, 1H, C1-H), 5.46 (d, J = 2.8 Hz, 1H, C2-H) ppm. 13C-NMR (CDCl3-CD3OD 1:1 v/v, 100.6 
MHz) δ = 14.3 (q), 20.7 (t), 20.8 (t), 23.2 (t), 26.3 (t), 29.9 (t), 30.0 (t), 30.2 (t), 31.1 (t), 31.2 (t), 
32.5 (t), 62.9 (t), 66.3 (d), 66.9 (t, JC-P = 1.9 Hz), 70.4 (d, JC-P = 1.0 Hz), 71.8 (d), 73.1 (d), 94.3 
(d), 170.8 (s), 171.5 (s), 171.8 (s) ppm. 31P-NMR (CDCl3-CD3OD 1:1 v/v, 161.6 MHz) δ = -3.6 















(4S)-Methylheptacosylphosphoryl-β-D-mannopyranoside ((4S)-18): (4S)-β-16 (7.8 mg, 9.50 
µmol) was dissolved in DCM-MeOH (0.6 ml, 1:1 v/v) and Et3N was added (20 µl, 0.15 mmol, 
14.0 eq). The resulting solution was stirred at room temperature for 2 days, observing the 
formation of a white solid. The mixture was concentrated and the resulting solid was washed with 
DCM-MeOH (1:1 v/v) to give (4S)-β-17 (5.1 mg, 7.81 µmol). 1H-NMR (CDCl3-CD3OD-D2O 
1.0:1.0:0.1 v/v/v, 400 MHz) δ = 0.85 (d, J = 6.4 Hz, 3H), 0.88 (t, J = 6.8 Hz, 3H), 1.02-1.45 (m, 
47H), 1.61 (m, 2H), 3.31 (m, 1H, C5-H), 3.56 (m, 2H, C3-H and C4-H), 3.73 (dd, J = 6.0, 12.4 
Hz, 1H, C6-H), 3.85 (m, 3H, C6-H’ and CH2-OP), 3.94 (d, J = 2.4 Hz, 1H, C2-H), 5.08 (d, J = 
8.4 Hz, 1H, C1-H) ppm. 13C-NMR (CDCl3-CD3OD- D2O 1.0:1.0:0.1 v/v/v, 100.6 MHz) δ = 14.5 
(q), 19.8 (q), 23.3 (t), 27.8 (t), 30.0 (t), 30.3 (t), 30.7 (t), 32.6 (t), 33.4 (d), 33.7 (t), 37.8 (t), 53.1, 
61.9, 67.3, 71.9, 72.0, 73.9, 96.2 (s) ppm. 31P-NMR (CDCl3-CD3OD-D2O 1.0:1.0:0.1 v/v/v, 161.6 















(4R)-Methylheptacosylphosphoryl-β-D-mannopyranoside ((4R)-18): (4R)-β-16 (8.2 mg, 9.99 
µmol) was dissolved in DCM-MeOH (0.6 ml, 1:1 v/v) and Et3N was added (20 µl, 0.14 mmol, 
13.0 eq). The resulting solution was stirred at room temperature for 2 days, observing the 
formation of a white solid. The mixture was concentrated and the resulting solid was washed with 
DCM-MeOH (1:1 v/v) to give (4R)-β-17 (4.9 mg, 7.51 µmol). Positive ion ESI-HRMS calcd for 















Heptacosylphosphoryl-β-D-mannopyranoside (19): β-17 (5.8 mg, 7.19 µmol) was dissolved in 
DCM-MeOH (0.6 ml, 1:1 v/v) and Et3N was added (20 µl, 0.14 mmol, 14.0 eq). The resulting 
solution was stirred at room temperature for 2 days, observing the formation of a white solid. The 
mixture was concentrated and the resulting solid was washed with DCM-MeOH (1:1 v/v) to give 
β-19 (3.8 mg, 5.95 µmol). 1H-NMR (CDCl3-CD3OD- D2O 1.0:1.0:0.1 v/v/v, 400 MHz) δ = 0.87 
(t, J = 6.8 Hz, 3H), 1.02-1.38 (m, 48H), 1.60 (m, 2H), 3.31 (m, 1H, C5-H), 3.55 (m, 2H, C3-H 
and C4-H), 3.72 (dd, J = 5.6, 12.0 Hz, 1H, C6-H), 3.86 (m, 3H, C6-H’ and CH2-OP), 3.93 (m, 1H, 
C2-H), 5.07 (d, J = 7.6 Hz, 1H, C1-H) ppm. 31P-NMR (CDCl3-CD3OD-D2O 1.0:1.0:0.1 v/v/v, 
161.6 MHz) δ = -0.8 ppm. Positive ion ESI-HRMS calcd for C33H67O9P (M+Na)+: 661.442, 
found: 661.445. 
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